Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 18,500 shares at $184.52 ($3.3M) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Open-market sale of $3.3M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $178.35 | 1,698 | $303K | 9.1% |
| 2 | $178.35 | 1,698 | $303K | 9.1% |
| 3 | $179.28 | 2,202 | $395K | 11.8% |
| 4 | $179.28 | 2,202 | $395K | 11.8% |
| 5 | $180.29 | 2,298 | $414K | 12.4% |
| 6 | $180.29 | 2,298 |
| $414K |
| 12.4% |
| 7 | $181.31 | 2,302 | $417K | 12.5% |
| 8 | $181.31 | 2,302 | $417K | 12.5% |
| 9 | $182.16 | 700 | $128K | 3.8% |
| 10 | $183.30 | 500 | $92K | 2.7% |
| 11 | $184.52 | 300 | $55K | 1.7% |
| Total | $180.17 avg | 18,500 | $3.3M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |